BioPharma

Daily updates on COVID-19 vaccine - 24 September 2021 September 24, 2021

The US has extended its authorisation of Pfizer-BioNTech to allow a booster dose for senior and vulnerable populations while Australia has committed to donating an additional 40 million doses to the Indo-Pacific region by the end of 2022.

TGA rushes out another iteration of the COVID-19 advertising authorisation September 24, 2021

The challenge facing the TGA when it comes to the promotion of incentives for people to be vaccinated against COVID-19 has taken yet another twist.

Lockdown-driven delay hardly cuts it for PHARMAC review September 24, 2021

Health minister Andrew Little attributed the failure to deliver the interim report of the PHARMAC review by 20 August to the COVID-19 lockdown that did not start until 17 August.

Repurposing treatments for COVID-19 is not so simple September 24, 2021

Some of the Australian-based industry's most senior medical leaders have co-authored a new paper with a range of experts on the challenges of repurposing medicines for COVID-19.

Amgen mandates COVID-19 vaccine for in-field staff September 24, 2021

Amgen has announced that it will require all in-field staff to be fully vaccinated against COVID-19 by 30 November 2021 but has left the door open to extending the mandate to all staff.

Sanofi marks 30 years of humanitarian program September 24, 2021

Sanofi's employees across Australia and New Zealand have joined members of the community to recognise this year’s 30th anniversary of its Humanitarian Program.

AstraZeneca welcomes expanded approval for Forxiga September 24, 2021

AstraZeneca has announced that the TGA has extended the approval of FORXIGA (dapagliflozin) to include chronic kidney disease.

MTPConnect joins industry funding to government-backed research September 24, 2021

Health minister Greg Hunt and MTPConnect have announced the recipients of over $9 million in grants under two initiatives jointly funded by the federal government and industry.

Japanese patent for Imugene's HER-Vaxx immunotherapy September 23, 2021

Clinical stage immuno-oncology company Imugene (ASX:IMU) has announced it has received a notice of grant from the Japanese Patent Office for its application to protect its HER-Vaxx immunotherapy.

A new board chair for Rhythm Biosciences September 23, 2021

Rhythm Biosciences (ASX:RHY) has announced the appointment of a new chair with the resignation of incumbent Shane Tanner.

Victoria funds creation of Health Innovation Centre at Monash September 23, 2021

Monash University has announced it will establish a Victorian Health Innovation Centre, including a flagship cardiovascular disease-focused research accelerator, HeartLabs, as well as a new focal point for clinical trials.

Perth cardiac team first to perform new procedure for severe heart valve disorder September 23, 2021

A structural heart team at Mount Hospital in Perth have become the first doctors in the Asia-Pacific region to successfully perform a minimally invasive heart procedure using a new ground-breaking device.

Latest Video

Most Read

Gilead mandates COVID-19 vaccine for its Australian team

Might it be the right time for another more important review?

TGA rushes out another iteration of the COVID-19 advertising authorisation

Making the case for change is not 'undermining', it is making the case for change

Legislating the agreements might need to navigate election timing

New Stories

Daily updates on COVID-19 vaccine - 24 September 2021

TGA rushes out another iteration of the COVID-19 advertising authorisation

Lockdown-driven delay hardly cuts it for PHARMAC review

Repurposing treatments for COVID-19 is not so simple

Amgen mandates COVID-19 vaccine for in-field staff

Sanofi marks 30 years of humanitarian program

AstraZeneca welcomes expanded approval for Forxiga

Sign In

Latest Video

Most Read

Gilead mandates COVID-19 vaccine for its Australian team

Might it be the right time for another more important review?

TGA rushes out another iteration of the COVID-19 advertising authorisation

Making the case for change is not 'undermining', it is making the case for change

Legislating the agreements might need to navigate election timing

Follow Us

New Stories

Daily updates on COVID-19 vaccine - 24 September 2021

TGA rushes out another iteration of the COVID-19 advertising authorisation

Lockdown-driven delay hardly cuts it for PHARMAC review

Repurposing treatments for COVID-19 is not so simple

Amgen mandates COVID-19 vaccine for in-field staff

Sanofi marks 30 years of humanitarian program

AstraZeneca welcomes expanded approval for Forxiga